Chancellor Reeves Aims for Targeted Measures on Living Costs in Upcoming Financial Plan
Treasury head Reeves has stated she is preparing "targeted action to tackle cost of living pressures" in next month's Budget.
During an interview with the BBC, she stated that reducing inflation is a collective task of both the administration and the Bank of England.
The UK's price growth is expected to be the most elevated among the Group of Seven advanced economies this year and the following year.
Potential Energy Cost Interventions
Sources suggest the government could take action to lower utility costs, for instance by slashing the present 5% rate of VAT applied on energy supplies.
Another approach is to cut some of the government charges currently included in household expenses.
Budgetary Constraints and Expert Predictions
The government will receive the next assessment from the official forecaster, the OBR, on the start of the week, which will clarify how much room there is for these measures.
The consensus from most economists is that the Chancellor will have to introduce tax increases or budget cuts in order to meet her self-imposed borrowing rules.
Previously on Thursday, estimates indicated there was a £22bn gap for the chancellor to resolve, which is at the more modest range of expectations.
"There's a joint job between the central bank and the administration to continue tackling some of the sources of price increases," Reeves stated to reporters in the US capital, at the conferences of the IMF and global financial institution.
Tax Commitments and International Concerns
While a great deal of the attention has been on expected tax rises, the chancellor said the most recent data from the OBR had not changed her vow to campaign commitments not to increase tax levels on earnings tax, VAT or social security contributions.
She blamed an "uncertain world" with growing geopolitical and commercial concerns for the Budget tax moves, likely to be focused on those "with the broadest shoulders."
International Trade Tensions
Commenting on apprehensions about the United Kingdom's trade ties with China she said: "The UK's security interests invariably take priority."
Recent statement by Chinese authorities to tighten export controls on critical minerals and other resources that are crucial for high-technology manufacturing led US President Donald Trump to suggest an further 100% tariff on goods from China, raising the possibility of an all-out trade war between the two economic giants.
The American finance chief labeled the Chinese move "economic coercion" and "a global supply chain control attempt."
Inquired about accepting the American proposal to join its dispute with China, Reeves said she was "very concerned" by China's actions and called on the Chinese government "to avoid restrictions and limit trade."
She said the decision was "bad for the global economy and generates additional challenges."
"In my view there are sectors where we should address China, but there are also important chances to export to China's economy, including financial services and other sectors of the economy. We've got to achieve that balance appropriate."
The Treasury chief also affirmed she was working with G7 counterparts "regarding our own essential resources approach, so that we are reduced dependence."
Health Service Medicine Costs and Funding
The Chancellor also admitted that the price the National Health Service spends on medicines could rise as a result of current talks with the Trump administration and its drugs companies, in exchange for reduced taxes and investment.
Some of the world's largest pharmaceutical manufacturers have said in recent statements that they are either delaying or canceling investments in the UK, with several blaming the modest returns they are getting.
Recently, the government science advisor said the price the health service spends on drugs would need to go up to stop firms and pharmaceutical investment leaving the United Kingdom.
The Chancellor informed the BBC: "We have seen due to the cost structure, that drug testing, recent pharmaceuticals have not been offered in the United Kingdom in the way that they are in other European countries."
"Our aim is to guarantee that patients getting care from the NHS are can obtain the finest essential medicines in the globe. And so we are looking at this situation, and... seeking to secure additional capital into Britain."